Economics ❯ Healthcare Economics ❯ Drug Pricing Strategies ❯ Market Competition

Consumer Impact

Trump Pledges Sharp Cuts to GLP-1 Drug Prices as Novo, Lilly Shares Slide

CMS says price talks on GLP-1 drugs are not finished.

White House Secures Pfizer Deal on Drug Prices With TrumpRx Discounts and $70 Billion U.S. Investment